Janssen and Stand Up To Cancer Collaborate For Oncology Patient Diversity
In June 2022, Stand Up To Cancer® (SU2C) announced sponsorship of an initiative with the Janssen Pharmaceutical Companies of Johnson &...
Stay updated with breaking news from Research Includes Me. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In June 2022, Stand Up To Cancer® (SU2C) announced sponsorship of an initiative with the Janssen Pharmaceutical Companies of Johnson &...
/PRNewswire/ -- Over 680 in-person and virtual attendees were at the Black Health Matters Spring Health Summit, held on Saturday, April 30th, 2022 from 9 am -...
/PRNewswire/ -- As the nation continues to recover from the effects of the COVID-19 pandemic, vaccine hesitancy, lack of access to quality health care, and...
Janssen's Best Practices For Patient Diversity Success By Ed Miseta, Chief Editor, Clinical Leader Follow Me On Twitter @EdClinical As devastating as the COVID pandemic has been, one positive result is the increased attention it has shed on the pharmaceutical industry. Because of the quest to stop the spread of COVID and save lives, the public is now more aware of the difficulty of finding cures and vaccines, and the need for clinical trials. One report has even showed an improvement in the reputation of pharma. “With COVID there's a greater understanding about clinical research,” said Ca...